$AQU
Aquaron Acquisition Corp. Stock $aqu

$aqu Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067250 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$130.0K	$270.0K	$10.00K
YoY Change		2600.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$130.0K	$270.0K	$10.00K
YoY Change		2600.0%
Operating Profit	-$127.4K	-$272.6K	-$5.027K
YoY Change	105209.92%	5322.08%
Interest Expense	$450.0K	$670.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$320.0K	$390.0K	-$10.00K
YoY Change		-4000.0%
Income Tax	$91.92K	$210.5K
% Of Pretax Income	28.73%	53.98%
Net Earnings	$253.3K	$311.1K	-$5.027K
YoY Change	-209409.92%	-6288.6%	2874.56%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.06	$0.04	$0.00
COMMON SHARES
Basic Shares Outstanding	4.553M shares	7.040M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.26M	$56.83M	$30.00K
YoY Change	156208.28%	189344.93%	-75.0%
Cash & Equivalents		$65.63K	$34.51K
Short-Term Investments	$31.26M	$56.77M
Other Short-Term Assets	$180.0K	$240.0K	$280.0K
YoY Change	-64.0%	-14.29%	154.55%
Inventory
Prepaid Expenses	$70.85K	$146.9K
Receivables
Other Receivables
Total Short-Term Assets	$31.45M	$57.07M	$310.0K
YoY Change	6066.86%	18309.82%	40.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$31.45M	$57.07M	$310.0K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$31.45M	$57.07M	$310.0K
YoY Change	6007.12%	18309.82%	40.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$200.0K	$200.0K	$0.00
YoY Change
Accrued Expenses	$30.00K	$20.00K
YoY Change	-85.12%
Deferred Revenue
YoY Change
Short-Term Debt	$760.0K	$760.0K	$300.0K
YoY Change	153.33%	153.33%	50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.068M	$29.94M	$300.0K
YoY Change	710.85%	9880.19%	50.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.068M	$29.94M	$300.0K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$4.068M	$29.94M	$300.0K
YoY Change	710.85%	9880.19%	50.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.879M	-$3.457M
YoY Change	33087.76%
Common Stock	$163.00	$163.00
YoY Change	13.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.878M	-$3.457M	$13.43K
YoY Change
Total Liabilities & Shareholders Equity	$31.45M	$57.07M	$310.0K
YoY Change	6007.12%	18309.82%	40.91%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$253.3K	$311.1K	-$5.027K
YoY Change	-209409.92%	-6288.6%	2874.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$70.00K	-$210.0K	-$60.00K
YoY Change	-240.0%	250.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$25.74M	$110.0K
YoY Change
Cash From Investing Activities	$25.74M	$110.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-25.73M	130.0K	-30.00K
YoY Change	42783.33%	-533.33%	-125.0%
NET CHANGE
Cash From Operating Activities	-70.00K	-210.0K	-60.00K
Cash From Investing Activities	25.74M	110.0K
Cash From Financing Activities	-25.73M	130.0K	-30.00K
Net Change In Cash	-60.00K	30.00K	-90.00K
YoY Change	500.0%	-133.33%	-175.0%
FREE CASH FLOW
Cash From Operating Activities	-$70.00K	-$210.0K	-$60.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Franchisor Costs FranchisorCosts		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	AQUARON ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-41470
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2760193
	dei	Entity Address Address Line1 EntityAddressAddressLine1	515 Madison Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	8th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	970 2181
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4553150	shares
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65634	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57284	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	146899	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	222346	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	90077	usd
CY2023Q2	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	56767844	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	55421229	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	57070454	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	55700859	usd
CY2023Q2	us-gaap	Assets Assets	57070454	usd
CY2022Q4	us-gaap	Assets Assets	55700859	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	99846	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	203846	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	140075	usd
CY2023Q2	aqu	Franchise Tax Payable FranchiseTaxPayable	18886	usd
CY2022Q4	aqu	Franchise Tax Payable FranchiseTaxPayable	13086	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	229089	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	51753	usd
CY2023Q2	aqu	Exercise Tax Payables ExerciseTaxPayables	259438	usd
CY2023Q2	aqu	Promissory Note Related Party PromissoryNoteRelatedParty	549626	usd
CY2023Q2	aqu	Promissory Note Bestpath01 PromissoryNoteBestpath01	210000	usd
CY2023Q2	aqu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2525896	usd
CY2022Q4	aqu	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	2525896	usd
CY2023Q2	aqu	Redeemed Common Stock Payable To Public Stockholders RedeemedCommonStockPayableToPublicStockholders	25943774	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	29940555	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2830656	usd
CY2023Q2	us-gaap	Liabilities Liabilities	29940555	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2830656	usd
CY2023Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	0.0001
CY2023Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2930090	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2930090	shares
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2930090	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2930090	shares
CY2023Q2	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	30586448	usd
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	47571463	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	163	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5138905	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3456712	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	159672	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3456549	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5298740	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57070454	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55700859	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	260468	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5027	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	601314	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7170	usd
CY2023Q2	us-gaap	Franchisor Costs FranchisorCosts	12100	usd
	us-gaap	Franchisor Costs FranchisorCosts	24100	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-272568	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5027	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-625414	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7170	usd
CY2023Q2	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	645451	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1021107	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	21872	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	234253	usd
CY2023Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	394755	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5027	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	629946	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-7170	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	210530	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	257116	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-126876	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-90077	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	311101	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5027	usd
	us-gaap	Net Income Loss NetIncomeLoss	462907	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7170	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5298740	usd
CY2023Q1	aqu	Stock Issued During Period Value Accretion Of Common Stock To Redemption Value StockIssuedDuringPeriodValueAccretionOfCommonStockToRedemptionValue	-4135212	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	151806	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1315334	usd
CY2023Q2	aqu	Stock Issued During Period Value Accretion Of Common Stock To Redemption Value StockIssuedDuringPeriodValueAccretionOfCommonStockToRedemptionValue	-4823546	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-259438	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	311101	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3456549	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20604	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2143	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	18461	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5027	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13434	usd
	us-gaap	Net Income Loss NetIncomeLoss	462907	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7170	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1021107	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	234253	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-75447	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	63771	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-47940	usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable	5800	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	257116	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-90077	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-480396	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55110	usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	118746	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	118746	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	370000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	26936	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	370000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72764	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8350	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17654	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57284	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16860	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65634	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34514	usd
	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue	8958759	usd
	aqu	Redeemed Common Stock Payable RedeemedCommonStockPayable	25943774	usd
	aqu	Exercise Tax Payable Charged Against Retained Earnings ExerciseTaxPayableChargedAgainstRetainedEarnings	259438	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	79780	usd
	aqu	Deposit From Bestpath Into Trust Account DepositFromBestpathIntoTrustAccount	210000	usd
	aqu	Other Payable Due To Related Party OtherPayableDueToRelatedParty	99846	usd
CY2022Q4	us-gaap	Investment Unrestricted Purchase Price Date Per Unit InvestmentUnrestrictedPurchasePriceDatePerUnit	10
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	750000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2022Q4	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	4171800	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	125154	usd
CY2023Q2	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P185D
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000001	usd
CY2023Q2	aqu	Redemption Shares RedemptionShares	2487090	shares
	us-gaap	Redemption Premium RedemptionPremium	25943774	usd
	us-gaap	Investment Company Redemption Fee Per Share InvestmentCompanyRedemptionFeePerShare	10.43
CY2023Q2	us-gaap	Business Combination Consideration Transferred Including Equity Interest In Acquiree Held Prior To Combination1 BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1	210000	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	50000	usd
	aqu	Trust Account Per Share TrustAccountPerShare	10.15
CY2023Q2	us-gaap	Equity Fair Value Disclosure EquityFairValueDisclosure	1200000000	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2023Q2	us-gaap	Investments And Cash InvestmentsAndCash	65634	usd
CY2023Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	660862	usd
	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	25000	usd
CY2023Q2	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	300000	usd
CY2023Q1	aqu	Spponsor Loan SpponsorLoan	100000	usd
CY2023Q1	aqu	Spponsor Loan SpponsorLoan	140000	usd
CY2023Q1	aqu	Spponsor Loan SpponsorLoan	130000	usd
CY2023Q2	aqu	Spponsor Loan SpponsorLoan	79780	usd
	aqu	Due From Related Partie DueFromRelatedPartie	99846	usd
CY2023Q2	us-gaap	Loans Assumed1 LoansAssumed1	210000	usd
CY2022Q3	us-gaap	Derivative Average Forward Interest Rate DerivativeAverageForwardInterestRate	0.01	pure
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.01	pure
	aqu	Exercise Tax Liability ExerciseTaxLiability	259438	usd
CY2023Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities		usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q2	us-gaap	Cash Cash	65634	usd
CY2022Q4	us-gaap	Cash Cash	57284	usd
CY2023Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	56767844	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	55421229	usd
	aqu	Interests Earned InterestsEarned	1021107	usd
CY2022Q4	aqu	Promissory Note Related Party PromissoryNoteRelatedParty		usd
CY2022Q4	aqu	Promissory Note Bestpath01 PromissoryNoteBestpath01		usd
CY2022Q4	aqu	Redeemed Common Stock Payable To Public Stockholders RedeemedCommonStockPayableToPublicStockholders		usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company complies with the requirements of Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (the “ASC”) Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs are allocated between public shares and public rights based on the estimated fair values of public shares and public rights at the date of issuance. Deferred offering costs consisted principally of underwriting, legal, accounting and other expenses were charged to stockholders’ equity upon the completion of the IPO on October 6, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2119	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2652	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	311101	usd
CY2022Q2	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-5027	usd
	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	462907	usd
	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-7170	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4823547	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	8958759	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-4512446	usd
CY2022Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-5027	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-8495852	usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-7170	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. As of June 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment		usd
	aqu	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	8958759	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	54171800	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6446444	usd
CY2022	aqu	Allocation Of Offering Costs Related To Redeemable Shares AllocationOfOfferingCostsRelatedToRedeemableShares	-3714253	usd
CY2022	aqu	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	3560360	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	47571463	usd
	aqu	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	8958759	usd
CY2023Q2	aqu	Redeemed Common Stock Payable To Public Stockholders RedeemedCommonStockPayableToPublicStockholders	25943774	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	30586448	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Property And Other Taxes Payable IncreaseDecreaseInPropertyAndOtherTaxesPayable		usd
CY2022Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	5000000	shares
CY2022Q4	us-gaap	Share Price SharePrice	10
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q4	aqu	Proceed From Issuance Initial Public Offering ProceedFromIssuanceInitialPublicOffering	125154	usd
CY2021Q2	aqu	Aggregate Price AggregatePrice	25000	usd
CY2021Q2	aqu	Share Issued And Outstanding Percentage ShareIssuedAndOutstandingPercentage	0.20	pure
	aqu	Subject To Certain Limited Exceptions Percentage SubjectToCertainLimitedExceptionsPercentage	0.50	pure
CY2022Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	200000	usd
CY2022Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	100000	usd
CY2023Q2	us-gaap	Other Loans Payable OtherLoansPayable	179626	usd
CY2023Q2	us-gaap	Capital Units CapitalUnits	99846	usd
CY2023Q2	aqu	Promissory Notes Outstanding PromissoryNotesOutstanding	549626	usd
CY2022Q4	aqu	Promissory Notes Outstanding PromissoryNotesOutstanding	0	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	99846	usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred	99846	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.33
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	210000	usd
CY2022	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	0	usd
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	750000	shares
	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	812577	usd
	aqu	Gross Proceeds GrossProceeds	1896013	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	100	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	97509	shares
CY2022Q4	us-gaap	Percentage Of Weighted Average Cost Inventory PercentageOfWeightedAverageCostInventory	1.15	pure
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2021	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	187500	shares
CY2021	aqu	Initial Stockholders Percentage InitialStockholdersPercentage	0.20	pure
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	187500	shares
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1623060	shares
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1623060	shares
CY2023Q2	aqu	Subject To Possible Redemption SubjectToPossibleRedemption	2930090	shares
CY2022Q4	aqu	Subject To Possible Redemption SubjectToPossibleRedemption	5417180	shares
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	56767844	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	55421229	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	aqu	Accretion Of Common Stock To Redemption Value AccretionOfCommonStockToRedemptionValue		usd
	aqu	Redeemed Common Stock Payable RedeemedCommonStockPayable		usd
	aqu	Exercise Tax Payable Charged Against Retained Earnings ExerciseTaxPayableChargedAgainstRetainedEarnings		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	aqu	Deposit From Bestpath Into Trust Account DepositFromBestpathIntoTrustAccount		usd
	aqu	Other Payable Due To Related Party OtherPayableDueToRelatedParty		usd
CY2022Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue		usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue		usd
	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001861063

Files In Submission

Name	View Source	Status
0001213900-23-067250-index-headers.html	Edgar Link	pending
0001213900-23-067250-index.html	Edgar Link	pending
0001213900-23-067250.txt	Edgar Link	pending
0001213900-23-067250-xbrl.zip	Edgar Link	pending
aqu-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_aquaron.htm	Edgar Link	pending
f10q0623ex31-2_aquaron.htm	Edgar Link	pending
f10q0623ex32-1_aquaron.htm	Edgar Link	pending
f10q0623ex32-2_aquaron.htm	Edgar Link	pending
f10q0623_aquaron.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
aqu-20230630_cal.xml	Edgar Link	unprocessable
aqu-20230630_lab.xml	Edgar Link	unprocessable
aqu-20230630_pre.xml	Edgar Link	unprocessable
aqu-20230630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_aquaron_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AQU
Aquaron Acquisition Corp. Stock $aqu

2023 Q3 Form 10-Q Financial Statement

#000121390023067250 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU Aquaron Acquisition Corp. Stock $aqu

2023 Q3 Form 10-Q Financial Statement

#000121390023067250 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AQU
Aquaron Acquisition Corp. Stock $aqu